|Articles|June 1, 2005
- LCGC Europe-06-01-2005
- Volume 18
- Issue 6
Profiles in Practice Series: Metabolism Identification and Structural Characterization in Drug Discovery
Author(s)Michael P. Balogh
In this initial instalment, several MS technologies and strategies currently being applied to characterize drug candidates in early stage development are presented.
Advertisement
Articles in this issue
over 20 years ago
Separating Proteins by pI-Values — Can 2D LC Replace 2D GE?over 20 years ago
Overload or Minor PeakNewsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on LCGC International
1
Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling
2
Navigating Adverse Reactions in GLP-1 Treatment
3
Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets
4
Shifting GLP-1 Receptor Agonists from Proteins to Small Molecules
5
